InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2424

Wednesday, 01/09/2019 2:48:56 PM

Wednesday, January 09, 2019 2:48:56 PM

Post# of 3283
Thanks for the update and context.

Based upon JTs stated strategy I don't see Spectrum making any efforts with Marqibo other than possible use of the Optimal>60 results to support or extent miserable current sales (around 4M per annum).

I really don't see them doing any phase III trials with Marqibo.

I just hope they complete Qapzola on schedule and file for approval.

Otherwise this is a Rolontis and Poziotinib company.

Best

TTB